403 related articles for article (PubMed ID: 20173736)
1. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
Visel A; Zhu Y; May D; Afzal V; Gong E; Attanasio C; Blow MJ; Cohen JC; Rubin EM; Pennacchio LA
Nature; 2010 Mar; 464(7287):409-12. PubMed ID: 20173736
[TBL] [Abstract][Full Text] [Related]
2. Deletion of chromosome 9p21 noncoding cardiovascular risk interval in mice alters Smad2 signaling and promotes vascular aneurysm.
Loinard C; Basatemur G; Masters L; Baker L; Harrison J; Figg N; Vilar J; Sage AP; Mallat Z
Circ Cardiovasc Genet; 2014 Dec; 7(6):799-805. PubMed ID: 25176937
[TBL] [Abstract][Full Text] [Related]
3. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells.
Motterle A; Pu X; Wood H; Xiao Q; Gor S; Ng FL; Chan K; Cross F; Shohreh B; Poston RN; Tucker AT; Caulfield MJ; Ye S
Hum Mol Genet; 2012 Sep; 21(18):4021-9. PubMed ID: 22706276
[TBL] [Abstract][Full Text] [Related]
4. 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response.
Harismendy O; Notani D; Song X; Rahim NG; Tanasa B; Heintzman N; Ren B; Fu XD; Topol EJ; Rosenfeld MG; Frazer KA
Nature; 2011 Feb; 470(7333):264-8. PubMed ID: 21307941
[TBL] [Abstract][Full Text] [Related]
5. Interferon-γ activates expression of p15 and p16 regardless of 9p21.3 coronary artery disease risk genotype.
Almontashiri NA; Fan M; Cheng BL; Chen HH; Roberts R; Stewart AF
J Am Coll Cardiol; 2013 Jan; 61(2):143-7. PubMed ID: 23199516
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.
Congrains A; Kamide K; Oguro R; Yasuda O; Miyata K; Yamamoto E; Kawai T; Kusunoki H; Yamamoto H; Takeya Y; Yamamoto K; Onishi M; Sugimoto K; Katsuya T; Awata N; Ikebe K; Gondo Y; Oike Y; Ohishi M; Rakugi H
Atherosclerosis; 2012 Feb; 220(2):449-55. PubMed ID: 22178423
[TBL] [Abstract][Full Text] [Related]
7. Resequencing and clinical associations of the 9p21.3 region: a comprehensive investigation in the Framingham heart study.
Johnson AD; Hwang SJ; Voorman A; Morrison A; Peloso GM; Hsu YH; Thanassoulis G; Newton-Cheh C; Rogers IS; Hoffmann U; Freedman JE; Fox CS; Psaty BM; Boerwinkle E; Cupples LA; O'Donnell CJ
Circulation; 2013 Feb; 127(7):799-810. PubMed ID: 23315372
[TBL] [Abstract][Full Text] [Related]
8. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
9. 9p21.3 Coronary Artery Disease Risk Variants Disrupt TEAD Transcription Factor-Dependent Transforming Growth Factor β Regulation of p16 Expression in Human Aortic Smooth Muscle Cells.
Almontashiri NA; Antoine D; Zhou X; Vilmundarson RO; Zhang SX; Hao KN; Chen HH; Stewart AF
Circulation; 2015 Nov; 132(21):1969-78. PubMed ID: 26487755
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 9p21 and coronary artery disease.
McPherson R
N Engl J Med; 2010 May; 362(18):1736-7. PubMed ID: 20445187
[No Abstract] [Full Text] [Related]
11. The chromosome 9p21.3 coronary heart disease risk allele is associated with altered gene expression in normal heart and vascular tissues.
Pilbrow AP; Folkersen L; Pearson JF; Brown CM; McNoe L; Wang NM; Sweet WE; Tang WH; Black MA; Troughton RW; Richards AM; Franco-Cereceda A; Gabrielsen A; Eriksson P; Moravec CS; Cameron VA
PLoS One; 2012; 7(6):e39574. PubMed ID: 22768093
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the murine ortholog of human 9p21.3 locus promotes atherosclerosis by increasing macrophage proinflammatory activity.
Kettunen S; Ruotsalainen AK; Örd T; Suoranta T; Heikkilä J; Kaikkonen MU; Laham-Karam N; Ylä-Herttuala S
Front Cardiovasc Med; 2023; 10():1113890. PubMed ID: 36950286
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus.
Jarinova O; Stewart AF; Roberts R; Wells G; Lau P; Naing T; Buerki C; McLean BW; Cook RC; Parker JS; McPherson R
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1671-7. PubMed ID: 19592466
[TBL] [Abstract][Full Text] [Related]
14. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
Weber RG; Hoischen A; Ehrler M; Zipper P; Kaulich K; Blaschke B; Becker AJ; Weber-Mangal S; Jauch A; Radlwimmer B; Schramm J; Wiestler OD; Lichter P; Reifenberger G
Oncogene; 2007 Feb; 26(7):1088-97. PubMed ID: 16909113
[TBL] [Abstract][Full Text] [Related]
15. CDKN2B gene expression is affected by 9p21.3 rs10757278 in CAD patients, six months after the MI.
Zivotić I; Djurić T; Stanković A; Milasinovic D; Stankovic G; Dekleva M; Marković Nikolić N; Alavantić D; Zivković M
Clin Biochem; 2019 Nov; 73():70-76. PubMed ID: 31386834
[TBL] [Abstract][Full Text] [Related]
16. Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: what have we learned from GWASs?
Hannou SA; Wouters K; Paumelle R; Staels B
Trends Endocrinol Metab; 2015 Apr; 26(4):176-84. PubMed ID: 25744911
[TBL] [Abstract][Full Text] [Related]
17. CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels.
Nanda V; Downing KP; Ye J; Xiao S; Kojima Y; Spin JM; DiRenzo D; Nead KT; Connolly AJ; Dandona S; Perisic L; Hedin U; Maegdefessel L; Dalman J; Guo L; Zhao X; Kolodgie FD; Virmani R; Davis HR; Leeper NJ
Circ Res; 2016 Jan; 118(2):230-40. PubMed ID: 26596284
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression.
Cunnington MS; Santibanez Koref M; Mayosi BM; Burn J; Keavney B
PLoS Genet; 2010 Apr; 6(4):e1000899. PubMed ID: 20386740
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large B-cell lymphomas.
Guney S; Bertrand P; Jardin F; Ruminy P; Kerckaert JP; Tilly H; Bastard C
Genes Chromosomes Cancer; 2011 Sep; 50(9):715-25. PubMed ID: 21638516
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 9p21 and coronary risk--the mystery continues.
Linsel-Nitschke P; Schunkert H
Atherosclerosis; 2011 Feb; 214(2):257-8. PubMed ID: 21146821
[No Abstract] [Full Text] [Related]
[Next] [New Search]
